Results 191 to 200 of about 6,467,172 (346)

THE GAUSES OF ACUTE ABDOMINAL PAIN IN THE HEALTHY, EXCLUSIVE OF TRAUMATISM [PDF]

, 1903
Jackson Thomas
openalex   +1 more source

Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

Stroke, 1993
Timothy Carter, J. W. Tulloch, Mario Mendez, R. Tarrel, M. Nance, Scott R. Budlie, R. Shapiro, K. Ruggles, P. Gottschalk, Rodney W. Sorenson, D. Jacobson, John G. Schmidt   +11 more
semanticscholar   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

Assessment of Prognostic Factors of Acute Hepatitis Among Pediatric Patients: A Cross-Sectional Study. [PDF]

JGH Open
Ezoddin N, Ziamanesh F, Ramandi A, Rohani P, Sohouli M, Alimadadi H.   +5 more
europepmc   +1 more source

ACUTE GASTRIC DILATATION [PDF]

, 1914
W. P. Mason, N. Evans
openalex   +1 more source

ACUTE APPENDICITIS AND ACUTE APPENDICULAR OBSTRUCTION. [PDF]

The Lancet, 1914
openaire   +4 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Study of the Photoinduced Fate of Selected Contaminants in Surface Waters by HPLC-HRMS. [PDF]

Rapid Commun Mass Spectrom
Sesia R, Bello FD, Medana C, Binetti R, Papagiannaki D, Calza P.   +5 more
europepmc   +1 more source

AN EPIDEMIC OF ACUTE PELLAGRA. [PDF]

, 1907
George H. Searcy
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source